Efficacy and safety of acoziborole in patients with human African trypanosomiasis caused by Trypanosoma brucei gambiense: a multicentre, open-label, single-arm, phase 2/3 trial User BestOfNoPoliticsBot, in the Science but without politics! subreddit, 03 Dec 2022